You searched for ustr - Page 10 of 152 - Knowledge Ecology International

The USTR Special 301 Reports, 1989 to 2017

The USTR’s Special 301 Report has been issued every year beginning in 1989. The Executive Summary of the 2009 report says:
Continue Reading →

India’s Department of Industrial Policy and Promotion creates IPR Think Tank to Draft National IPR Policy

Posted on October 24, 2014 by Thiru

On Friday, 24 October 2014, India’s Department of Industrial Policy and Promotion (DIPP) announced the creation of an IPR Think Tank to Draft National Intellectual Property Rights Policy.

The composition of the think tank follows:

Justice Prabha Sridevan, Chairperson, IPR Think Tank;
Ms. Pratibha Singh, Advocate, Singh & Singh Associates, Member;
Ms. Punita Bhargava, Advocate, Inventure IP, Member;
Dr. Unnat Pandit, Cadila Pharmaceuticals Limited, Member;
Continue Reading →

Comments to USTR on the Out-of-Cycle Review for India due October 31, 2014.

Posted on October 24, 2014 by KEI Staff

Continue Reading →

Money speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP

Posted on August 5, 2014 by KEI Staff

As part of a partial response to FOIA request, USTR has provided KEI with copies of 13 letters sent by members of Congress, from July 27, 2011 to August 8, 2013, on the topic of biologic drug test data provisions in the TPP negotiation. We had obtained several but not all of these letters earlier from a variety of sources, including from PhRMA’s web page — where some had been proudly displayed. (See link below).

Were there letters on the other side? Yes, three. (see below).

With the FOIA request, we have also obtained the responses to the letters.

Continue Reading →

EU’s TTIP Anti-Transparency Rules laid out in DG-Trade letter to USTR

Posted on July 1, 2014 by Claire Cassedy

Previously, KEI reported on the terms of reference (TOR) for the confidentiality of the Transatlantic Trade and Investment Partnership (TTIP) negotiating texts, as laid out in a letter by USTR to DG-Trade. Although evidently publicly available, the EU counterpart of that letter was not accessible through the FOIA process. Obtained through the EU Regulation (EC) No. Continue Reading →

TTIP: Anti-Transparency Rules laid out in USTR letter to DG-Trade

Posted on June 13, 2014 by Claire Cassedy

KEI has obtained the terms of reference (TOR) for the confidentiality of the negotiating texts of the Transatlantic Trade and Investment Partnership (TTIP) Agreement. The TOR are laid out in a two-page letter from US Chief Negotiator Dan Mullaney to EU Chief Negotiator Ignacio Garcia-Bercero which is available here. The letter was obtained through a FOIA request filed by KEI with the USTR on May 19, 2014.

Continue Reading →

WTO TRIPS Council (June 2014): USTR submission on Non-Violation Complaints Under the TRIPS Agreement

Posted on June 11, 2014 by Thiru

On 10 June 2014, the United States tabled a paper (IP/C/W/599) to the World Trade Organization’s (WTO) TRIPS Council on “Non-Violation Complaints Under the TRIPS Agreement.” This paper is expected to be discussed at the TRIPS Council today (11 June 2014) under agenda item 7 on “Non-Violation and Situation Complaints.”

As previously mentioned in our February 2014 piece,

Continue Reading →

32 Members of US House of Representatives ask USTR to sanction Canada for not granting patents on drugs

Posted on April 12, 2014 by James Love

The attached letter, dated April 10, 2014 and signed by a bipartisan group of 32 members of the House of Representatives, asks USTR to elevate Canada to the Special 301 “priority watch list,” for “violation of their international obligations” for not granting enough patents on “innovative medicines.” According to the members of Congress signing the letter, Canada is in violation of its WTO TRIPS obligations. Continue Reading →

KEI Comments regarding USTR Public Interest Trade Advisory Committee

Posted on March 26, 2014 by Claire Cassedy

Comments of KEI, regarding USTR Request For Comments From The Public On The Creation Of The Public Interest Trade Advisory Committee And Request For Nominees To That Committee.

Submitted to Regulations.gov on March 25, 2014, under docket number USTR-2014-0005.

Intellectual property issues are an important element of US trade agreements, and according to a recent study by Open Secrets, the most intensively lobbied issue, by far.

Continue Reading →

James Love on India bashing at USTR’s Feb 24, 2014 Special 301 hearing

Posted on February 25, 2014 by KEI Staff

Claire Cassedy did this interview at the KEI offices, following the February 24, 2014 USTR hearing on the Special 301.
Continue Reading →

Ambassador Michael Froman wants to block compulsory licenses on drug patents in India

Search Results for: ustr

The USTR Special 301 Reports, 1989 to 2017

India’s Department of Industrial Policy and Promotion creates IPR Think Tank to Draft National IPR Policy

Comments to USTR on the Out-of-Cycle Review for India due October 31, 2014.

Money speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP

EU’s TTIP Anti-Transparency Rules laid out in DG-Trade letter to USTR

TTIP: Anti-Transparency Rules laid out in USTR letter to DG-Trade

WTO TRIPS Council (June 2014): USTR submission on Non-Violation Complaints Under the TRIPS Agreement

32 Members of US House of Representatives ask USTR to sanction Canada for not granting patents on drugs

KEI Comments regarding USTR Public Interest Trade Advisory Committee

James Love on India bashing at USTR’s Feb 24, 2014 Special 301 hearing

Categories